These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunological heterogeneity of hepatic alanine:glyoxylate aminotransferase in primary hyperoxaluria type 1. Wise PJ, Danpure CJ, Jennings PR. FEBS Lett; 1987 Sep 28; 222(1):17-20. PubMed ID: 2443389 [Abstract] [Full Text] [Related]
6. Alanine glyoxylate aminotransferase deficiency: biochemical and molecular genetic lessons from the study of a human disease. Watts RW. Adv Enzyme Regul; 1992 Sep 28; 32():309-27. PubMed ID: 1496924 [Abstract] [Full Text] [Related]
11. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1. Leiper JM, Oatey PB, Danpure CJ. J Cell Biol; 1996 Nov 28; 135(4):939-51. PubMed ID: 8922378 [Abstract] [Full Text] [Related]
12. Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. Purdue PE, Takada Y, Danpure CJ. J Cell Biol; 1990 Dec 28; 111(6 Pt 1):2341-51. PubMed ID: 1703535 [Abstract] [Full Text] [Related]
13. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1. Danpure CJ. J Nephrol; 1998 Dec 28; 11 Suppl 1():8-12. PubMed ID: 9604801 [Abstract] [Full Text] [Related]
14. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase. Oppici E, Roncador A, Montioli R, Bianconi S, Cellini B. Biochim Biophys Acta; 2013 Dec 28; 1832(12):2277-88. PubMed ID: 24055001 [Abstract] [Full Text] [Related]
15. [Molecular pathology of type 1 primary hyperoxaluria]. Cochat P, Rolland MO, Bozon D, Dumontel C, Divry P. Nephrologie; 1994 Dec 28; 15(6):375-80. PubMed ID: 7862225 [Abstract] [Full Text] [Related]
16. Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase. Danpure CJ. Biochimie; 1993 Dec 28; 75(3-4):309-15. PubMed ID: 8507692 [Abstract] [Full Text] [Related]
17. Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity. Danpure CJ, Jennings PR, Fryer P, Purdue PE, Allsop J. J Inherit Metab Dis; 1994 Dec 28; 17(4):487-99. PubMed ID: 7967498 [Abstract] [Full Text] [Related]
18. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways. Danpure CJ. Biochim Biophys Acta; 2006 Dec 28; 1763(12):1776-84. PubMed ID: 17027096 [Abstract] [Full Text] [Related]
19. Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation. Purdue PE, Allsop J, Isaya G, Rosenberg LE, Danpure CJ. Proc Natl Acad Sci U S A; 1991 Dec 01; 88(23):10900-4. PubMed ID: 1961759 [Abstract] [Full Text] [Related]
20. A new micro-assay for human liver alanine: glyoxylate aminotransferase. Allsop J, Jennings PR, Danpure CJ. Clin Chim Acta; 1987 Dec 01; 170(2-3):187-93. PubMed ID: 3436053 [Abstract] [Full Text] [Related] Page: [Next] [New Search]